1.00 / AMA PRA Category 1 Credit(s)TM
Up to half of all postmenopausal women will experience some degree of vulvovaginal atrophy. This interactive, 60-minute enduring webcast will provide ob/gyns and other healthcare providers with the latest evidence on how to initiate conversations about issues of sexual/urogenital health in postmenopausal women, and how to diagnosis and treat symptomatic vulvovaginal atrophy, taking into consideration the unique needs of each woman.
Ob/gyns and other healthcare providers involved in women’s health.
After taking part in this educational activity, participants should be better able to:
The North American Menopause Society (NAMS) requires faculty, planners, managers, and other individuals who are in a position to control the content of this activity are to disclose and real or apparent conflict of interest they may have as related to the content of this activity. This information is disclosed to CME activity participants. NAMS identifies and thoroughly reviews and resolves all identified conflicts of interest before the activity's release. In addition, faculty members are asked to disclose any discussion of off-label use of pharmaceuticals and devices and to use nonproprietary names for these whenever possible.
Susan Basilico, Krista Sierra, and Stacy Clapp of Haymarket Medical Education have nothing to disclose.
AMA PRA Category 1 Credit(s)TM
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of The North American Menopause Society (NAMS) and Haymarket Medical Education. NAMS is accredited by the ACCME to provide continuing medical education for physicians.
NAMS designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This educational activity may contain discussion of investigational uses of agents or devices or off-label uses of approved agents or devices. The North American Menopause Society, Novo Nordisk, Inc., and Haymarket Medical Education (HME) do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of The North American Menopause Society, Novo Nordisk Inc., or HME. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
To obtain credit, a score of 70% or better is required. This CME is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.
If you have any questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.